25 February 2018
News and Views
Links and Services
A study in this month's issue of Gut investigates prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.
Non-steroidal anti-inflammatory drug (NSAID) use decreases both the incidence of colorectal cance
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors